Executive leadership team named for the combined Allergan Pfizer business
8 February 2016 | By Victoria White
The close of the transaction to combine Pfizer and Allergan is expected in the second half of 2016, and is subject to certain conditions...
List view / Grid view
News
BIO-Europe Spring® 2016 Event in Sweden this April will bring 2,000+ life science executives to Stockholm-Uppsala region
8 February 2016 | By EBD Group
The tenth annual BIO-Europe Spring® springtime international life science partnering conference will be held in Stockholm, Sweden, April 4–6, 2016...
RedHill Biopharma and IZI enter RP101 collaboration
8 February 2016 | By Victoria White
The research collaboration will test RP101 in preclinical oncology models in combination with standard-of-care chemotherapies to support existing Phase I and Phase II clinical data...
New toolkit informs of the risks of taking valproate during pregnancy
8 February 2016 | By Victoria White
Valproate is associated with a risk of birth defects and developmental disorders in children born to women who take the treatment during pregnancy...
NICE says ‘no’ to alirocumab in draft guidance
8 February 2016 | By Victoria White
NICE was concerned that alirocumab had not been compared with the combination therapy of ezetimibe plus a statin and that trials of the drug were not able to provide robust information on cardiovascular outcomes...
FDA approves expanded use of Daklinza in HCV genotypes 1 and 3
8 February 2016 | By Victoria White
The expanded label for Daklinza includes three additional patient populations: HCV patients with HIV-1 coinfection, advanced cirrhosis, or post-liver transplant recurrence of HCV...
ImmunoGen and Merck collaborate for ovarian cancer trial
5 February 2016 | By Victoria White
The companies are to are to assess ImmunoGen’s mirvetuximab soravtansine in combination with Merck’s Keytruda (pembrolizumab) in FRα-positive ovarian cancer...
Public Accounts Committee publishes report on the Cancer Drugs Fund
5 February 2016 | By Victoria White
A Public Accounts Committee has released its recommendations for the reform of the Cancer Drugs Fund...
Honeywell completes acquisition of research chemicals business from Sigma-Aldrich
5 February 2016 | By Honeywell
The acquisition broadens Honeywell’s research chemicals portfolio and expands the company's global reach...
Aridhia’s Dr David Sibbald honoured with Outstanding Contribution Award
5 February 2016 | By Victoria White
Dr David Sibbald OBE, co-founder and Chairman of Aridhia, was awarded the ‘Outstanding Contribution Award’ at the Scottish Enterprise Life Sciences Awards...
Muzammil Mansuri is Sanofi’s new Executive Committee member
5 February 2016 | By Victoria White
Mr. Mansuri joins Sanofi from Gilead Sciences and will take the position of Executive Vice President, Strategy & Business Development...
Positive topline results from GAUSS-3 trial of Repatha
5 February 2016 | By Victoria White
The Phase 3 GAUSS-3 trial evaluating Amgen’s Repatha (evolocumab) in patients with high cholesterol who cannot tolerate statins met its co-primary endpoints...
NovaBiotics wins Life Science Investment of the Year Award
5 February 2016 | By Victoria White
NovaBiotics was awarded the Life Science Investment of the Year Award at the Scottish Enterprise Life Sciences Annual Awards...
Ocean Optics Expands Flame Spectrometer Line with Versatile Miniature NIR Spectrometer
Flame-NIR puts the power of NIR analysis in a small-footprint instrument...
Phase 3 study of Blincyto in ALL meets primary endpoint
5 February 2016 | By Victoria White
Blincyto is a BiTE antibody construct that binds specifically to CD19 expressed on the surface of cells of B-lineage origin and CD3 expressed on the surface of T cells...
